TELMISARTAN
- Product NDC
- 62135-535
- 11-digit product format
- 621350535
- Labeler code
- 62135
- Product ID
- 62135-535_459ee4aa-32df-2119-e063-6294a90a0e7a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- TELMISARTAN
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Chartwell RX, LLC.
- Application
- ANDA078710
- Marketing category
- ANDA
- Marketing start
- 2020-11-23
- Substance
- TELMISARTAN
- Active strength
- 20 mg/1
- Pharmacologic classes
- Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- TELMISARTAN
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TELMISARTAN | 20 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | U5SYW473RQ |
| Rxcui | 205304, 205305, 282755 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 62135-535-30 | TELMISARTAN | 30 in 1 BOTTLE | TABLET | 30 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 62135-535 | TELMISARTAN TABLET [CHARTWELL RX, LLC.] | 2 | Current NDC, 1 package rows | 20241031_beaaf383-730f-4411-b5e7-15c32b53a338.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 62135-535-30 | 62135053530 | 30 TABLET in 1 BOTTLE (62135-535-30) | 30 tablet | 2023-03-08 | No | No | Historical |